DJIA 17,098.45 18.88 0.11%
NASDAQ 4,580.27 22.58 0.50%
S&P 500 2,003.37 6.63 0.33%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

60.11 0.11 (0.18%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MRK $60.11 0.18%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $60.42
Previous Close $60.00
Daily Range $59.83 - $60.42
52-Week Range $44.62 - $60.58
Market Cap $173.4B
P/E Ratio 31.58
Dividend (Yield) $1.76 (2.9%)
Ex-Dividend Date
Dividend Pay Date
Volume 5,715,779
Average Daily Volume 7,920,588
Current FY EPS $3.50





Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website:

News & Commentary Rss Feed

Has Gilead Sciences, Inc.'s Star Drug Already Peaked?

Prescriptions of Gilead Sciences' hepatitis C drug Sovaldi peaked, but sales will pick up after the new combination product is approved.

Bristol-Myers Squibb Gets European Approval For HCV Drug Daklinza

IYH, PFE, MRK, UNH: ETF Inflow Alert

Dow Analyst Moves: MRK

I Am Sure This Pharma-Company Suits Your Portfolio

Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt Figures

3 Stocks Reiterated As A Buy: PCLN, AAPL, MRK

3 Reasons Merck & Co., Inc.'s Stock Could Fall

Merck's hepatitis C and oncology drug hopefuls have been pushing its stock higher, but these three catalysts could halt its growth prospects dead in their tracks.

Short Interest Swings in High-Yield Dividend Stocks

Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold

See More MRK News...

MRK's Top Competitors

MRK $60.11 (0.18%)
Current stock: MRK
JNJ $103.73 (0.76%)
Current stock: JNJ
NVS $89.84 (0.12%)
Current stock: NVS
RHHBY $36.51 (-0.14%)
Current stock: RHHBY